article Open AccessTop 1% cited
Cytomegalovirus in Solid Organ Transplantation
American Journal of Transplantation · 2013 · Vol. 13 · pp. 93–106
Raymund R. Razonable✉(University of Rochester)Atul Humar(University of Alberta)
Cytomegalovirus and herpesvirus researchHerpesvirus Infections and TreatmentsParvovirus B19 Infection StudiesMedicineCytomegalovirusAsymptomaticOrgan transplantationImmunologyVirologySeroprevalenceTransplantationHuman cytomegalovirusCytomegalovirus infection
MeSH terms
Antiviral AgentsCytomegalovirus InfectionsHumansRisk FactorsOrgan Transplantation
Citations
535
FWCI
27.48
field-weighted impact
References
95
Percentile
100%
vs. same field & year
Citations per year
Cited by
Infection in Organ Transplantation
American Journal of Transplantation · 2017 · 773 citations
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
Transplantation · 2018 · 1,113 citations
References
Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients
American Journal of Transplantation · 2004 · 880 citations
Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients
American Journal of Transplantation · 2007 · 423 citations
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients
American Journal of Transplantation · 2010 · 493 citations
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
Clinical Infectious Diseases · 2002 · 1,235 citations
American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation
American Journal of Transplantation · 2006 · 482 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.